This study was designed to investigate the effect of
Trolox, a hydrophilic analogue of
vitamin E, on the alteration of vasoregulatory gene expression during hepatic
ischemia and reperfusion (I/R). Rats were subjected to 60 min of hepatic
ischemia in vivo. The rats were treated intravenously with
Trolox (2.5 mg/kg) or the vehicle as a control 5 min before reperfusion. Liver samples were obtained 5 h after reperfusion for a RT-PCR analysis on the
mRNA for the genes of interest. These
mRNA peptides are
endothelin-1 (ET-1), potent
vasoconstrictor peptide, its receptor ET(A) and ET(B),
vasodilator endothelial nitric oxide synthase (eNOS),
inducible nitric oxide synthase (iNOS),
heme oxygenase-1 (HO-1),
tumor necrosis factor-alpha (
TNF-alpha) and
cyclooxygenase-2 (COX-2). It was seen that serum
alanine aminotransferase and lipid peroxidation levels were markedly increased after I/R and
Trolox significantly suppressed this increase. In contrast, the
glutathione concentration decreased in the I/R group, and this decrease was inhibited by
Trolox. ET-1
mRNA expression was increased by I/R, an increase which was prevented by
Trolox. The
mRNA levels for ET(A) receptor was significantly decreased, whereas ET(B) receptor transcript increased in the I/R group. The increase in ET(A) was prevented by
Trolox. The
mRNA levels for iNOS and HO-1 significantly increased in the I/R group and
Trolox attenuated this increase. There were no significant differences in eNOS
mRNA expression among any of the experimental groups. The
mRNA levels for COX-2 and
TNF-alpha significantly increased in I/R group and
Trolox also attenuated this increase. Our findings suggest that I/R induces an imbalanced hepatic vasoregulatory gene expression and
Trolox ameliorates this change through its
free radical scavenging activity.